Johnson & Johnson has agreed to a settlement in order to avoid a trial that was slated to begin in Pennsylvania state court on Nov. 1 in the latest case over abnormal breast growth that adolescent boys have suffered after taking the antipsychotic drug Risperdal. The case was filed by the family of a boy (identified only as “N.F.”) who allegedly began using Risperdal at age 6 to treat symptoms of Asperger’s syndrome. The terms of the settlement are confidential.
The case would have been the sixth case to go to trial over claims that J&J subsidiary Janssen Pharmaceuticals Inc. worked to obscure the risk of abnormal breast growth, a condition known as gynecomastia, faced by young boys taking the powerful antipsychotic medication.
This would have been the first case to go to trial since a jury hit J&J with a $70 million verdict on behalf of a Risperdal plaintiff in July. There are now more than 2,000 Risperdal-related cases pending as part of a mass tort program in Philadelphia. The three other verdicts in Risperdal cases tried in Philadelphia have resulted in $4.75 million in damages for Plaintiffs. In another case, there was a win for J&J. A jury in that case found there was insufficient evidence to show the Plaintiff’s injuries had been caused by the medication. The successful cases are all either tied up in post-trial motions or on appeal to the state’s Superior Court.
The Plaintiffs are represented by Tom Kline and Christopher Gomez of Kline & Specter PC, and Jason Itkin, Kelly Woods, Cesar Tavares, Cory Itkin and Santana McMurrey of Arnold & Itkin LLP. The cases are N.F. et al. v. Janssen Pharmaceuticals Inc. et al. and C.W. et al. v Janssen Pharmaceuticals et al. both before the Court of Common Pleas of Philadelphia County, Pennsylvania.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.